<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1237" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1237/" /><meta name="ncbi_pagename" content="Rothmund-Thomson Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Rothmund-Thomson Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Rothmund-Thomson Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/01/03" /><meta name="citation_author" content="Lisa L Wang" /><meta name="citation_author" content="Sharon E Plon" /><meta name="citation_pmid" content="20301415" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1237/" /><meta name="citation_keywords" content="ATP-dependent DNA helicase Q4" /><meta name="citation_keywords" content="RECQL4" /><meta name="citation_keywords" content="Rothmund-Thomson Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Rothmund-Thomson Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Lisa L Wang" /><meta name="DC.Contributor" content="Sharon E Plon" /><meta name="DC.Date" content="2019/01/03" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1237/" /><meta name="description" content="Rothmund-Thomson syndrome (RTS) is characterized by a rash that progresses to poikiloderma; sparse hair, eyelashes, and/or eyebrows; small size; skeletal and dental abnormalities; cataracts; and an increased risk for cancer, especially osteosarcoma. The skin is typically normal at birth; the rash of RTS develops between ages three and six months as erythema, swelling, and blistering on the face, subsequently spreading to the buttocks and extremities. The rash evolves over months to years into the chronic pattern of reticulated hypo- and hyperpigmentation, punctate atrophy, and telangiectasias, collectively known as poikiloderma. Hyperkeratotic lesions occur in approximately one third of individuals. Skeletal abnormalities include radial ray defects, ulnar defects, absent or hypoplastic patella, and osteopenia." /><meta name="og:title" content="Rothmund-Thomson Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Rothmund-Thomson syndrome (RTS) is characterized by a rash that progresses to poikiloderma; sparse hair, eyelashes, and/or eyebrows; small size; skeletal and dental abnormalities; cataracts; and an increased risk for cancer, especially osteosarcoma. The skin is typically normal at birth; the rash of RTS develops between ages three and six months as erythema, swelling, and blistering on the face, subsequently spreading to the buttocks and extremities. The rash evolves over months to years into the chronic pattern of reticulated hypo- and hyperpigmentation, punctate atrophy, and telangiectasias, collectively known as poikiloderma. Hyperkeratotic lesions occur in approximately one third of individuals. Skeletal abnormalities include radial ray defects, ulnar defects, absent or hypoplastic patella, and osteopenia." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1237/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/rts/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1237/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE891F00E03F49810000000009BC03E6.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1237_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1237_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/rbs/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/rotor/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1237_"><span class="title" itemprop="name">Rothmund-Thomson Syndrome</span></h1><p class="contrib-group"><span itemprop="author">Lisa L Wang</span>, MD and <span itemprop="author">Sharon E Plon</span>, MD, PhD, FACMG.</p><a data-jig="ncbitoggler" href="#__NBK1237_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1237_ai__"><div class="contrib half_rhythm"><span itemprop="author">Lisa L Wang</span>, MD<div class="affiliation small">Associate Professor, Division of Hematology/Oncology<br />Department of Pediatrics<br />Texas Children's Cancer Center<br />Texas Children's Hospital<br />Baylor College of Medicine<br />Houston, Texas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.mcb@gnawll" class="oemail">ude.mcb@gnawll</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Sharon E Plon</span>, MD, PhD, FACMG<div class="affiliation small">Professor, Departments of Pediatrics and Molecular and Human Genetics<br />Texas Children's Hospital<br />Baylor College of Medicine<br />Houston, Texas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.mcb@nolps" class="oemail">ude.mcb@nolps</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">October 6, 1999</span>; Last Update: <span itemprop="dateModified">January 3, 2019</span>.</p><p><em>Estimated reading time: 21 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="rts.Summary" itemprop="description"><h2 id="_rts_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Rothmund-Thomson syndrome (RTS) is characterized by a rash that progresses to poikiloderma; sparse hair, eyelashes, and/or eyebrows; small size; skeletal and dental abnormalities; cataracts; and an increased risk for cancer, especially osteosarcoma. The skin is typically normal at birth; the rash of RTS develops between ages three and six months as erythema, swelling, and blistering on the face, subsequently spreading to the buttocks and extremities. The rash evolves over months to years into the chronic pattern of reticulated hypo- and hyperpigmentation, punctate atrophy, and telangiectasias, collectively known as poikiloderma. Hyperkeratotic lesions occur in approximately one third of individuals. Skeletal abnormalities include radial ray defects, ulnar defects, absent or hypoplastic patella, and osteopenia.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of RTS is established by clinical findings (in particular, the characteristic rash) and/or the identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>RECQL4</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Surgical removal of cataracts; standard treatment for cancer; pulsed dye laser to the telangiectatic component of the rash for cosmetic management. Calcium and vitamin D supplements may be warranted in individuals with osteopenia or a history of fractures.</p><p><i>Surveillance:</i> Annual physical and eye examination, monitoring of skin for lesions with unusual color or texture, screening for osteosarcoma.</p><p><i>Agents/circumstances to avoid:</i> Excessive exposure to heat or sunlight; growth hormone for those with short stature with normal growth hormone levels.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>RTS is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives, prenatal testing for pregnancies at increased risk, and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible if the <i>RECQL4</i> pathogenic variants in the family are known.</p></div></div><div id="rts.Diagnosis"><h2 id="_rts_Diagnosis_">Diagnosis</h2><div id="rts.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Rothmund-Thomson syndrome (RTS) <b>should be suspected</b> in individuals with the classic rash of RTS.</p><p><b>Acute phase</b></p><ul><li class="half_rhythm"><div>Starts in infancy, usually between ages three and six months</div></li><li class="half_rhythm"><div>Erythema on the cheeks and face</div></li><li class="half_rhythm"><div>Spreads to involve the extensor surfaces of the extremities</div></li><li class="half_rhythm"><div>Typically sparing of the trunk and abdomen; possible involvement of the buttocks</div></li></ul><p><b>Chronic phase</b></p><ul><li class="half_rhythm"><div>Gradually develops over a period of months to years</div></li><li class="half_rhythm"><div>Reticulated hyper- and hypopigmentation, telangiectasias, and areas of punctate atrophy (i.e., poikiloderma)</div></li><li class="half_rhythm"><div>Persists throughout life</div></li></ul><p>If the rash is atypical (either in appearance, distribution, or pattern of onset and spread), a diagnosis of <i>probable</i> RTS can be made if two other features of RTS are present:</p><ul><li class="half_rhythm"><div>Sparse scalp hair, eyelashes, and/or eyebrows</div></li><li class="half_rhythm"><div>Small size, usually symmetric for height and weight</div></li><li class="half_rhythm"><div>Gastrointestinal disturbance as young children, usually consisting of chronic vomiting and diarrhea, sometimes requiring feeding tubes</div></li><li class="half_rhythm"><div>Skeletal abnormalities including radial ray defects, ulnar defects, absent or hypoplastic patella, osteopenia, abnormal trabeculation</div></li><li class="half_rhythm"><div>Dental abnormalities that include rudimentary or hypoplastic teeth, enamel defects, delayed tooth eruption</div></li><li class="half_rhythm"><div>Nail abnormalities such as dysplastic or poorly formed nails</div></li><li class="half_rhythm"><div>Hyperkeratosis particularly of the soles of the feet</div></li><li class="half_rhythm"><div>Cataracts, usually juvenile, bilateral</div></li><li class="half_rhythm"><div>Cancers including skin cancers (basal cell carcinoma and squamous cell carcinoma) and in particular bone cancer (osteosarcoma)</div></li></ul></div><div id="rts.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of RTS <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the classic rash of RTS with onset, spread, and appearance described above and/or <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>RECQL4</i> identified on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1237/table/rts.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figrtsTmoleculargenetictestingusedin" rid-ob="figobrtsTmoleculargenetictestingusedin">Table 1</a>).</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of Rothmund-Thomson syndrome is broad, individuals with the distinctive findings described in <a href="#rts.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#rts.Option_1">Option 1</a>), whereas those with atypical findings in whom the diagnosis of Rothmund-Thomson syndrome has not been considered are more likely to be diagnosed using genomic testing (see <a href="#rts.Option_2">Option 2</a>).</p><div id="rts.Option_1"><h4>Option 1</h4><p>When the phenotypic and laboratory findings suggest the diagnosis of Rothmund-Thomson syndrome, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>RECQL4</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected. Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first. For this gene, optimal sequence analysis would include not only the coding and splice junction regions but also the exceptionally short introns, where a small <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> may be pathogenic because it renders the <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> too short for proper <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> [<a class="bk_pop" href="#rts.REF.wang.2002.165">Wang et al 2002</a>] (see <a href="#rts.Molecular_Genetics">Molecular Genetics</a>). Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> may be considered if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found; however, no exon or whole-gene deletions/duplications have thus far been identified as a cause of RTS.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>RECQL4</i> and other genes of interest (see <a href="#rts.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul></div><div id="rts.Option_2"><h4>Option 2</h4><p>When the diagnosis of Rothmund-Thomson syndrome is not considered because an individual has atypical phenotypic features, <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is the most commonly used genomic testing method; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="rts.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Rothmund-Thomson Syndrome (RTS)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1237/table/rts.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__rts.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_rts.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_rts.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_rts.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_rts.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>RECQL4</i></td><td headers="hd_h_rts.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_rts.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~60%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_rts.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_rts.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_rts.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td><td headers="hd_h_rts.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_rts.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="rts.TF.1.1"><p class="no_margin">See <a href="/books/NBK1237/#rts.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="rts.TF.1.2"><p class="no_margin">See <a href="#rts.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="rts.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="rts.TF.1.4"><p class="no_margin">Authors, unpublished data from the RTS Registry</p></div></dd><dt>5. </dt><dd><div id="rts.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="rts.TF.1.6"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd><dt>7. </dt><dd><div id="rts.TF.1.7"><p class="no_margin">In nearly 40% of individuals with the typical clinical findings of RTS, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> fails to identify a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>RECQL4</i>, making the existence of one or more additional causative genes likely [<a class="bk_pop" href="#rts.REF.wang.2003.669">Wang et al 2003</a>; Authors, personal observation].</p></div></dd></dl></div></div></div></div></div></div><div id="rts.Clinical_Characteristics"><h2 id="_rts_Clinical_Characteristics_">Clinical Characteristics</h2><div id="rts.Clinical_Description"><h3>Clinical Description</h3><p>Individuals with Rothmund-Thomson syndrome (RTS) can exhibit few or many of the associated clinical features. The severity of the features (e.g., rash) also varies.</p><p><b>Skin.</b> Children with RTS typically develop a rash between ages three and six months but occasionally as late as age two years. The skin changes begin as erythema, swelling, and occasionally blistering on the face, then spread to the buttocks and extremities. Gradually over a period of months to years the skin changes become chronic, with reticulated hypo- and hyperpigmentation, telangiectasias, and punctate atrophy (collectively referred to as poikiloderma) that persist throughout life.</p><p>Hyperkeratotic lesions occur in approximately one third of individuals.</p><p>Uncommon but reported findings [<a class="bk_pop" href="#rts.REF.mak.2006.401">Mak et al 2006</a>] include the following:</p><ul><li class="half_rhythm"><div class="half_rhythm">Calcinosis, the formation of calcium deposits in the skin, usually at the site of an injury</div><div class="half_rhythm">Note: Calcinosis cutis differs from osteoma cutis, which is true bone formation.</div></li><li class="half_rhythm"><div class="half_rhythm">Porokeratosis, a sign of disordered keratinization. This has been reported in one person with RTS, and thus may or may not be a related finding.</div></li></ul><p><b>Teeth.</b> Many individuals with RTS also have dental abnormalities including rudimentary or hypoplastic teeth, microdontia, delayed eruption, supernumerary and congenitally missing teeth, ectopic eruption, and increased incidence of caries [<a class="bk_pop" href="#rts.REF.hayta_.2002.479">Hayta&#x000e7; et al 2002</a>].</p><p><b>Hair.</b> Children with RTS may have sparse scalp hair or even total alopecia. Eyelashes and/or eyebrows may also be sparse or absent.</p><p><b>Growth.</b> Most individuals with RTS are the result of a full-term pregnancy but tend to have low birth weight and length for gestational age. They remain small throughout their lives, usually below the fifth percentile for both weight and height. Growth hormone levels appear to be normal.</p><p><b>Skeleton.</b> A study of 28 individuals with RTS examined by skeletal survey found that 75% had at least one major skeletal abnormality [<a class="bk_pop" href="#rts.REF.mehollinray.2008.w626">Mehollin-Ray et al 2008</a>].</p><p>Findings included abnormal trabeculation with longitudinal and transverse metaphyseal striations, dysplastic changes in the phalanges, absent or malformed bones (e.g., aplastic radii, malformed ulnae, hypoplastic thumbs), fused bones, osteopenia, and hypoplastic or absent patella.</p><p>In a study of metabolic bone disease in 29 individuals with a clinical diagnosis of RTS, a significant proportion were found to have decreased bone mineral density as well as history of fractures [<a class="bk_pop" href="#rts.REF.cao.2017.3046">Cao et al 2017</a>]. Additionally, the presence of pathogenic variants in <i>RECQL4</i> and low bone mineral density correlated with the history of increased risk of fractures [<a class="bk_pop" href="#rts.REF.cao.2017.3046">Cao et al 2017</a>].</p><p><b>Gastrointestinal.</b> Some infants or young children with RTS have feeding difficulties or other gastrointestinal problems including chronic emesis or diarrhea. Although feeding tubes are occasionally required, most of these problems resolve spontaneously during childhood [<a class="bk_pop" href="#rts.REF.wang.2001.11">Wang et al 2001</a>].</p><p><b>Hematologic.</b> Benign and malignant hematologic abnormalities including <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> anemia and neutropenia, myelodysplasia, aplastic anemia, and leukemia have been reported in individuals with RTS [<a class="bk_pop" href="#rts.REF.knoell.1999.444">Knoell et al 1999</a>, <a class="bk_pop" href="#rts.REF.porter.1999.452">Porter et al 1999</a>, <a class="bk_pop" href="#rts.REF.narayan.2001.210">Narayan et al 2001</a>, <a class="bk_pop" href="#rts.REF.pianigiani.2001.422">Pianigiani et al 2001</a>].</p><p><b>Cataract.</b> The prevalence of juvenile cataracts has been reported in some series to be as high as 50%, with onset usually between ages three and seven years. Earlier onset (as early as the first few months of life) and later onset (teens or adulthood) have also been reported. Most of the reports of early-onset, bilateral juvenile cataracts come from descriptions from Europe. In an international cohort of 41 individuals with RTS (age range 9 months to 42 years), the prevalence of cataracts was found to be much lower (&#x0003c;10), and none of the individuals had bilateral cataracts [<a class="bk_pop" href="#rts.REF.wang.2001.11">Wang et al 2001</a>].</p><p><b>Cancer.</b> The overall prevalence of cancers in adults with RTS is unknown.</p><ul><li class="half_rhythm"><div><b>Osteosarcoma</b> is the most commonly reported malignancy [<a class="bk_pop" href="#rts.REF.wang.2003.669">Wang et al 2003</a>]. In a cohort of those with RTS, the prevalence of osteosarcoma was 30% [<a class="bk_pop" href="#rts.REF.wang.2001.11">Wang et al 2001</a>]. The median age at diagnosis, 11 years, was slightly younger than that seen in the general population. Families in which more than one sib had RTS and osteosarcoma have been identified [<a class="bk_pop" href="#rts.REF.lindor.2000.223">Lindor et al 2000</a>, <a class="bk_pop" href="#rts.REF.wang.2001.11">Wang et al 2001</a>].</div></li><li class="half_rhythm"><div><b>Skin cancer.</b> Individuals with RTS are also at increased risk of developing skin cancer, including basal cell carcinoma and squamous cell carcinoma [<a class="bk_pop" href="#rts.REF.borg.1998.216">Borg et al 1998</a>] and melanoma [<a class="bk_pop" href="#rts.REF.howell.2008.416">Howell &#x00026; Bray 2008</a>]. The prevalence of skin cancers in individuals with RTS is estimated from the literature to be 5%. Skin cancer can occur at any age, although it often occurs earlier than in the general population. The mean age for epithelial tumors has been estimated at 34.4 years [<a class="bk_pop" href="#rts.REF.stinco.2008.154">Stinco et al 2008</a>]. <a class="bk_pop" href="#rts.REF.piquerocasals.2002.312">Piquero-Casals et al [2002]</a> report on a <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> Brazilian family with classic features of RTS including poikiloderma and bilateral cataracts. All three <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> sibs developed cutaneous squamous cell carcinoma in adulthood (age 35-48 years). The cancers occurred on non-sun-exposed surfaces.</div></li><li class="half_rhythm"><div><b>Second malignancy.</b> A few individuals with RTS have been reported to have a second malignancy. One developed non-Hodgkin lymphoma nine years after chemotherapy for osteosarcoma [<a class="bk_pop" href="#rts.REF.spurney.1998.494">Spurney et al 1998</a>], and another developed Hodgkin lymphoma eight years after therapy for osteosarcoma [<a class="bk_pop" href="#rts.REF.wang.2001.11">Wang et al 2001</a>]. In general, follow-up time for individuals with RTS and osteosarcoma has been too short to draw conclusions about the risk of secondary malignancy.</div></li><li class="half_rhythm"><div><b>Multiple primary cancers</b> have also been reported in individuals with RTS. For example, one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual developed anaplastic large-cell lymphoma at age nine years, diffuse large cell B lymphoma and osteosarcoma at age 14 years, and acute lymphoblastic leukemia at age 21 years. Whether the latter cancers represent secondary malignancies is not known [<a class="bk_pop" href="#rts.REF.simon.2010.1575">Simon et al 2010</a>].</div></li><li class="half_rhythm"><div><b>Chemotherapy effects.</b> Because RTS is felt to be a <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> instability syndrome, those treated for malignancy may in theory be more sensitive to the effects of chemotherapy and at a higher risk for second malignancy. However, from the limited number of individuals reported, it appears that most individuals with RTS and cancer treated with chemotherapy have not had significantly increased toxicities, although some individuals may experience increased mucositis with doxorubicin treatment [<a class="bk_pop" href="#rts.REF.hicks.2007.370">Hicks et al 2007</a>, <a class="bk_pop" href="#rts.REF.simon.2010.1575">Simon et al 2010</a>]. Other individuals have reported increased toxicities after treatment with high-dose methotrexate, but side effect profiles vary significantly among individuals and appear to be specific to the individual.</div></li></ul><p><b>Other.</b> Infertility has been described in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males and females; however, a few affected females have had normal pregnancies, and a few males have produced offspring.</p><p>Immunologic function appears to be intact. However, there are several isolated reports of individuals with RTS who have concomitant immune dysfunction. These include an individual who had humoral immune deficiency associated with granulomatous skin lesions [<a class="bk_pop" href="#rts.REF.de_somer.2010.37">De Somer et al 2010</a>], an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual with IgG<sub>4</sub> deficiency and recurrent sinopulmonary infections [<a class="bk_pop" href="#rts.REF.kubota.1993.406">Kubota et al 1993</a>], and another affected individual with low serum immunoglobulin (IgG and IgA) levels who presented with herpes encephalitis [<a class="bk_pop" href="#rts.REF.ito.1999.354">Ito et al 1999</a>]. One individual with RTS and severe combined immunodeficiency (T-B+NK- <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> with agammaglobulinemia) underwent successful hematopoietic stem cell transplantation [<a class="bk_pop" href="#rts.REF.broom.2006.337">Broom et al 2006</a>].</p><p>Most individuals with RTS appear to have normal intelligence.</p><p><b>Life span.</b> In the absence of malignancy, life span is probably normal, although follow-up data in the published literature are limited. Death from metastatic osteosarcoma and other cancers has been reported in a number of children and adults with RTS.</p></div><div id="rts.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have been identified.</p><p><a class="bk_pop" href="#rts.REF.wang.2003.669">Wang et al [2003]</a> found that individuals with RTS and one or two truncating pathogenic variants in <i>RECQL4</i> were at increased risk of developing osteosarcoma.</p></div><div id="rts.Nomenclature"><h3>Nomenclature</h3><p>"Poikiloderma congenitale," the name given by M Sidney Thomson to the disorder he described in 1923, has been used in the literature to describe RTS in the past.</p></div><div id="rts.Prevalence"><h3>Prevalence</h3><p>RTS is a rare disorder. Since its original description by Auguste Rothmund in Austria in 1868, fewer than 500 individuals have been described in the English-language literature.</p><p>RTS has been described in all ethnicities. No population appears to be at higher or lower risk for the disorder. However, specific pathogenic variants may exist within certain ethnic groups.</p><p>The population prevalence and <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> frequency of RTS are unknown [<a class="bk_pop" href="#rts.REF.larizza.2013.21">Larizza et al 2013</a>].</p></div></div><div id="rts.Genetically_Related_Allelic_Disorder"><h2 id="_rts_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p><b>RAPADILINO (<i>ra</i>dial <i>ra</i>y defect; <i>pa</i>tellae hypoplasia or aplasia and cleft or highly arched <i>pa</i>late; <i>di</i>arrhea and d<i>i</i>slocated joints; <i>li</i>ttle size and <i>li</i>mb malformation; <i>no</i>se slender and <i>no</i>rmal intelligence)</b> syndrome (OMIM <a href="http://omim.org/entry/266280" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">266280</a>) is characterized by pre- and postnatal growth retardation. Cervical spine segmentation defects have been reported. Failure to thrive results from feeding problems and juvenile diarrhea of unknown cause [<a href="https://www.ncbi.nlm.nih.gov/books/NBK1204/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Siitonen et al 2003</a>]. Since its original description in Finland [<a href="https://www.ncbi.nlm.nih.gov/books/NBK1204/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">K&#x000e4;&#x000e4;ri&#x000e4;inen et al 1989</a>], only 14 Finnish and two non-Finnish individuals have been reported [<a href="https://www.ncbi.nlm.nih.gov/books/NBK1204/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Vargas et al 1992</a>, <a href="https://www.ncbi.nlm.nih.gov/books/NBK1204/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Kant et al 1998</a>, <a href="https://www.ncbi.nlm.nih.gov/books/NBK1204/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Jam et al 1999</a>, <a href="https://www.ncbi.nlm.nih.gov/books/NBK1204/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Siitonen et al 2003</a>]. Osteosarcoma was reported in one of the 16 individuals. Lymphoma appears to be a frequent complication in individuals with RAPADILINO syndrome; it occurred in four patients before age 35 years [<a href="https://www.ncbi.nlm.nih.gov/books/NBK1204/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Siitonen et al 2009</a>].</p><p>The Finn-specific <i>RECQL4</i> <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variant (IVS7+2delT) associated with RAPADILINO syndrome leads to <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> skipping of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 7 that is predicted to remove 44 amino acids just before the conserved helicase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, apparently without altering transcription of the helicase domain itself. Nine of the 14 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> Finnish individuals are <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for IVS7+2delT and five are compound heterozygotes for IVS7+2delT and a <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variant in extra-helicase exons 5, 18, and 19, thus sparing in all cases the helicase domain, which is therefore thought to play a role in poikiloderma and predisposition to osteosarcoma [<a href="https://www.ncbi.nlm.nih.gov/books/NBK1204/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Siitonen et al 2003</a>].</p><p><a href="/books/n/gene/bgs/"><b>Baller-Gerold syndrome</b></a>
<b>(BGS)</b> is characterized by craniosynostosis (coronal suture most commonly involved), upper-limb anomalies (most commonly radial ray defects), short stature, and poikiloderma. Patellar hypoplasia or aplasia may become apparent in childhood. Eleven different <i>RECQL4</i> pathogenic variants have been reported in seven families with BGS with seven variants having been detected only in association with BGS. One case of lymphoma has been reported in an individual with Baller-Gerold syndrome [<a href="https://www.ncbi.nlm.nih.gov/books/NBK1204/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Debeljak et al 2009</a>].</p></div><div id="rts.Differential_Diagnosis"><h2 id="_rts_Differential_Diagnosis_">Differential Diagnosis</h2><p>The differential diagnosis of Rothmund-Thomson syndrome (RTS) includes the disorders summarized in <a class="figpopup" href="/books/NBK1237/table/rts.T.disorders_that_can_exhibit_feature/?report=objectonly" target="object" rid-figpopup="figrtsTdisordersthatcanexhibitfeature" rid-ob="figobrtsTdisordersthatcanexhibitfeature">Table 2</a>, which can exhibit features of poikiloderma but are otherwise clinically distinct from RTS.</p><div id="rts.T.disorders_that_can_exhibit_feature" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Disorders That Can Exhibit Features of Poikiloderma to Consider in the Differential Diagnosis of Rothmund-Thomson Syndrome (RTS)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1237/table/rts.T.disorders_that_can_exhibit_feature/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__rts.T.disorders_that_can_exhibit_feature_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Overlapping Clinical Features of This Disorder</th><th id="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing Clinical Features of This Disorder</th></tr></thead><tbody><tr><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/bloom/">Bloom syndrome</a>&#x000a0;<sup>1</sup></td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>BLM</i></td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Rash characterized by an erythematous, sun-sensitive lesion of the face; not true poikiloderma</div></li><li class="half_rhythm"><div>Loss of lower eyelashes &#x00026; blister &#x00026; fissure formation of lower lip common</div></li><li class="half_rhythm"><div>Caf&#x000e9; au lait macules or paired hypopigmented &#x00026; hyperpigmented macules in some</div></li><li class="half_rhythm"><div>Most common cause of death: cancer (occurring at younger-than-usual ages)</div></li><li class="half_rhythm"><div>Severe pre- &#x00026; postnatal growth deficiency w/&#x02193; subcutaneous fat</div></li></ul>
</td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Recurrent infections (otitis media &#x00026; pneumonia)</div></li><li class="half_rhythm"><div>Chronic pulmonary disease</div></li><li class="half_rhythm"><div>Diabetes mellitus</div></li></ul>
</td></tr><tr><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/werner/">Werner syndrome</a></td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>WRN</i></td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Initial findings (usually in 3<sup>rd</sup> decade): loss &#x00026; graying of hair, alopecia, scleroderma-like skin changes</div></li><li class="half_rhythm"><div>Skin ulcers (4th decade)</div></li><li class="half_rhythm"><div>Cancer predisposition</div></li></ul>
</td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Premature appearance of features associated w/normal aging</div></li><li class="half_rhythm"><div>Normal development until end of 1st decade</div></li><li class="half_rhythm"><div>1st symptom: no growth spurt during early teen years</div></li><li class="half_rhythm"><div>Initial signs: hoarseness followed by bilateral ocular cataracts, type 2 diabetes mellitus, hypogonadism, &#x00026; osteoporosis in 4<sup>th</sup> decade</div></li></ul>
</td></tr><tr><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/ataxia-telangiectas/">Ataxia-telangiectasia</a></td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ATM</i></td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Increased risk for malignancy, particularly leukemia &#x00026; lymphoma</div></li><li class="half_rhythm"><div>Unusual sensitivity to ionizing radiation</div></li></ul>
</td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Progressive cerebellar ataxia beginning ages 1-4 yrs</div></li><li class="half_rhythm"><div>Oculomotor apraxia</div></li><li class="half_rhythm"><div>Frequent infections</div></li><li class="half_rhythm"><div>Choreoathetosis</div></li><li class="half_rhythm"><div>Telangiectasias of the conjunctivae</div></li><li class="half_rhythm"><div>Immunodeficiency</div></li></ul>
</td></tr><tr><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/fa/">Fanconi anemia</a></td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;20 genes&#x000a0;<sup>2</sup></td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR<br />AD<br />XL</td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Abnormal skin pigmentation</div></li><li class="half_rhythm"><div>Increased risk of malignancy</div><ul><li class="half_rhythm"><div>10%-30% incidence of hematologic malignancies (primarily acute myeloid leukemia)</div></li><li class="half_rhythm"><div>25%-30% incidence of nonhematologic malignancies (solid tumors, particularly of head &#x00026; neck, skin, GI tract, &#x00026; genital tract)</div></li></ul></li></ul>
</td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Bone marrow failure in 1st decade; 90% estimated cumulative incidence of bone marrow failure by age 40-50 yrs</div></li><li class="half_rhythm"><div>Physical abnormalities: short stature; malformations of thumbs, forearms, skeletal system, eye, kidneys &#x00026; urinary tract, ear, heart, GI system, oral cavity, &#x00026; CNS; hearing loss; hypogonadism; DD</div></li></ul>
</td></tr><tr><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/xp/">Xeroderma pigmentosum</a></td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DDB2</i><br /><i>ERCC1</i><br /><i>ERCC2</i><br /><i>ERCC3</i><br /><i>ERCC4</i><br /><i>ERCC5</i><br /><i>POLH</i><br /><i>XPA</i><br /><i>XPC</i></td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Sun sensitivity (sunburn w/blistering, persistent erythema on minimal sun exposure in ~60% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, &#x00026; severe, marked freckle-like pigmentation of face @ age &#x0003c;2 years)</div></li><li class="half_rhythm"><div>Greatly &#x02191; risk of cutaneous neoplasms (basal cell carcinoma, squamous cell carcinoma, melanoma)</div></li><li class="half_rhythm"><div>Xerosis (dry skin)</div></li><li class="half_rhythm"><div>Poikiloderma</div></li><li class="half_rhythm"><div>Loss of lashes</div></li></ul>
</td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Median age of onset of non-melanoma skin cancer is &#x0003c;10 years.</div></li><li class="half_rhythm"><div>Neurologic manifestations in ~25%</div></li><li class="half_rhythm"><div>Photophobia</div></li><li class="half_rhythm"><div>Keratitis</div></li><li class="half_rhythm"><div>Atrophy of the skin of the lids</div></li></ul>
</td></tr><tr><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/kindler/">Kindler syndrome</a></td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FERMT1</i></td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Acral bullae at birth &#x00026; after minor trauma</div></li><li class="half_rhythm"><div>Diffuse poikiloderma w/striate &#x00026; reticulate atrophy</div></li><li class="half_rhythm"><div>Widespread eczematoid dermatitis</div></li><li class="half_rhythm"><div>Keratotic papules of hands, feet, elbows, knees</div></li><li class="half_rhythm"><div>Marked photosensitivity</div></li></ul>
</td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Esophageal &#x00026; urethral strictures</div></li><li class="half_rhythm"><div>Webbing of fingers &#x00026; toes</div></li><li class="half_rhythm"><div>No &#x02191; risk for cataract or malignancy</div></li></ul>
</td></tr><tr><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/dkc/">Dyskeratosis congenita</a></td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ACD</i><br /><i>CTC1</i><br /><i>DKC1</i><br /><i>NHP2</i><br /><i>NOP10</i><br /><i>PARN</i><br /><i>RTEL1</i><br /><i>TERC</i><br /><i>TERT</i><br /><i>TINF2</i><br /><i>WRAP53</i></td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL<br />AD<br />AR</td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Lacy reticular pigmentation of neck &#x00026; upper chest</div></li><li class="half_rhythm"><div>Nail dystrophy</div></li><li class="half_rhythm"><div>Increased risk of leukemia &#x00026; skin cancers</div></li></ul>
</td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Bone marrow failure</div></li><li class="half_rhythm"><div>Oral leukoplakia w/variable onset</div></li><li class="half_rhythm"><div>Not associated w/radial ray defects or cataracts</div></li></ul>
</td></tr><tr><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/poikiloderma-n/">Poikiloderma with neutropenia</a></td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>USB1</i></td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Rash</div></li><li class="half_rhythm"><div>Less common finding: acute myeloid leukemia</div></li></ul>
</td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Onset of rash differs from that seen in RTS: more eczematous, starting peripherally &#x00026; spreading centrally</div></li><li class="half_rhythm"><div>Rash affecting the trunk</div></li><li class="half_rhythm"><div>Not associated w/radial ray abnormalities</div></li><li class="half_rhythm"><div>Clinically significant neutropenia w/recurrent sinopulmonary infection</div></li><li class="half_rhythm"><div>Less common finding: bone marrow failure</div></li><li class="half_rhythm"><div>Paronychias common</div></li></ul>
</td></tr><tr><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/hfpoik-tmp/">Hereditary fibrosing poikiloderma with tendon contractures, myopathy, and pulmonary fibrosis</a></td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FAM111B</i></td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Poikiloderma (typically beginning in 1st 6 mos &#x00026; mainly facial)</div></li><li class="half_rhythm"><div>Chronic erythematous &#x00026; scaly skin lesions on extremities (distinct from chronic poikiloderma of extremities seen in RTS)</div></li><li class="half_rhythm"><div>Sclerosis of digits</div></li><li class="half_rhythm"><div>Mild palmoplantar keratoderma</div></li><li class="half_rhythm"><div>Scalp hair, eyelashes, &#x00026;/or eyebrows typically sparse</div></li><li class="half_rhythm"><div>Nail dysplasia in some</div></li></ul>
</td><td headers="hd_h_rts.T.disorders_that_can_exhibit_feature_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hypohidrosis w/heat intolerance</div></li><li class="half_rhythm"><div>Mild lymphedema of extremities</div></li><li class="half_rhythm"><div>Muscle contractures usually seen in childhood &#x00026; can be present as early as age 2 yrs</div></li><li class="half_rhythm"><div>In most: progressive weakness of proximal &#x00026; distal muscles of all 4 limbs</div></li><li class="half_rhythm"><div>In some adults: progressive interstitial pulmonary fibrosis that can be life-threatening w/in 3-4 yrs after respiratory symptoms appear</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; CNS = central nervouse system; DD = developmental delay; GI = gastrointestinal; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="rts.TF.2.1"><p class="no_margin">A greatly increased frequency of sister chromatid exchanges (SCEs) in cells exposed to bromodeoxyuridine (BrdU) is diagnostic. Bloom syndrome is the only disorder in which such evidence of hyper-<a class="def" href="/books/n/gene/glossary/def-item/recombination/">recombination</a> is known to occur.</p></div></dd><dt>2. </dt><dd><div id="rts.TF.2.2"><p class="no_margin">See <a href="https://omim.org/phenotypicSeries/PS227650" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Phenotypic Series: Fanconi Anemia </a>for a list of genes associated with this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in OMIM.</p></div></dd></dl></div></div></div></div><div id="rts.Management"><h2 id="_rts_Management_">Management</h2><div id="rts.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Rothmund-Thomson syndrome (RTS), the evaluations summarized in this section (if not performed as part of the evaluation that led to the diagnosis) are recommended:</p><ul><li class="half_rhythm"><div class="half_rhythm">Dermatologic evaluation</div></li><li class="half_rhythm"><div class="half_rhythm">Baseline skeletal radiographic examination by age five years to identify underlying skeletal abnormalities</div></li><li class="half_rhythm"><div class="half_rhythm">Baseline complete blood count with differential</div><div class="half_rhythm">Individuals with clinical evidence of anemia or cytopenias should be evaluated by CBC and bone marrow biopsy if clinically indicated.</div></li><li class="half_rhythm"><div class="half_rhythm">Ophthalmologic examination to evaluate for cataracts</div></li><li class="half_rhythm"><div class="half_rhythm">Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="rts.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Dermatologic.</b> Pulsed dye laser has been used for cosmetic management of the telangiectatic component of the rash [<a class="bk_pop" href="#rts.REF.potozkin.1991.162">Potozkin &#x00026; Geronemus 1991</a>].</p><p><b>Skeletal.</b> Calcium and vitamin D supplements may be warranted in individuals with osteopenia or a history of fractures [<a class="bk_pop" href="#rts.REF.cao.2017.3046">Cao et al 2017</a>].</p><p><b>Hematologic.</b> Individuals with hematologic abnormalities should be treated in the standard manner by a hematologist familiar with RTS.</p><p><b>Cataract.</b> Visually significant cataracts require surgical removal.</p><p><b>Cancer.</b> Affected individuals who develop cancer should be treated according to standard chemotherapy and/or radiation regimens. Doses should be modified only if the individual experiences significantly increased toxicities.</p></div><div id="rts.Surveillance"><h3>Surveillance</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div>Annual evaluation by a physician familiar with RTS for overall health maintenance and monitoring of growth</div></li><li class="half_rhythm"><div>Evaluation by a dermatologist annually or more frequently if indicated and otherwise close monitoring of the skin for lesions with unusual color or texture, as individuals with RTS are at increased risk for skin cancers</div></li><li class="half_rhythm"><div>For individuals without cataracts, yearly eye examinations for screening purposes</div></li><li class="half_rhythm"><div>Prompt skeletal radiographic examination when clinical suspicion of osteosarcoma is present (including bone pain, swelling, or an enlarging lesion on a limb) due to the high risk for this potentially lethal malignancy</div></li></ul></div><div id="rts.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Exposure to heat or sunlight may exacerbate the rash in some individuals.</p><p>Avoidance of excessive sun exposure decreases the risk for skin cancer.</p><p>Given the theoretic potential for tumorigenesis, growth hormone (GH) therapy is not recommended for individuals who have normal GH levels. For individuals with documented GH deficiency, standard treatment with growth hormone is appropriate.</p></div><div id="rts.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#rts.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="rts.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div><div id="rts.Other"><h3>Other</h3><p>Given the theoretic potential for tumorigenesis, growth hormone (GH) therapy is not recommended for individuals who have normal GH levels. For individuals with documented GH deficiency, routine treatment with growth hormone is appropriate.</p></div></div><div id="rts.Genetic_Counseling"><h2 id="_rts_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="rts.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Rothmund-Thomson syndrome (RTS) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="rts.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with confirmed <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>RECQL4</i> are obligate heterozygotes (i.e., carriers of one <i>RECQL4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are apparently asymptomatic, although this issue has not been carefully studied.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are apparently asymptomatic, although this issue has not been carefully studied.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The offspring of an individual with RTS are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>RECQL4</i>.</div></li><li class="half_rhythm"><div>The <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> frequency for RTS is unknown; however, given the rarity of the disorder, the likelihood that an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual will have children with a carrier is very low. Exceptions include areas in which a <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> may be present (e.g., western Austria, where Rothmund originally described RTS; and in the Mennonite population).</div></li></ul><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>RECQL4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="rts.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>RECQL4</i> pathogenic variants in the family.</p></div><div id="rts.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="rts.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> Once the <i>RECQL4</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for RTS are possible.</p><p><b>Ultrasound examination.</b> Ultrasound examination at 16 to 18 weeks' gestation may detect forearm reduction defects; however, given the variability of clinical findings, the absence of skeletal abnormalities on ultrasound examination in a fetus at risk does not exclude the possibility of RTS.</p><p>Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements.</p></div></div><div id="rts.Resources"><h2 id="_rts_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="https://ghr.nlm.nih.gov/condition/rothmund-thomson-syndrome" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Rothmund-Thomson syndrome</a></div></li><li class="half_rhythm"><div><b>Rothmund-Thomson Syndrome Foundation</b></div><div>RTS Foundation</div><div>4307 Woodward Court</div><div>Chantilly VA 20151</div><div><b>Email:</b> rtssupport@rtsplace.org</div><div><a href="http://www.rtsplace.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.rtsplace.org</a></div></li></ul></div><div id="rts.Molecular_Genetics"><h2 id="_rts_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="rts.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Rothmund-Thomson Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1237/table/rts.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__rts.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_rts.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_rts.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_rts.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_rts.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_rts.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_rts.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_rts.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/9401" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>RECQL4</i></a></td><td headers="hd_b_rts.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=9401" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">8q24<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_rts.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O94761" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ATP-dependent DNA helicase Q4</a></td><td headers="hd_b_rts.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/RECQL4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RECQL4 database</a></td><td headers="hd_b_rts.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=RECQL4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RECQL4</a></td><td headers="hd_b_rts.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=RECQL4[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RECQL4</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="rts.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="rts.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Rothmund-Thomson Syndrome (<a href="/omim/268400,603780" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1237/table/rts.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__rts.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/268400" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">268400</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ROTHMUND-THOMSON SYNDROME, TYPE 2; RTS2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603780" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603780</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">RECQ PROTEIN-LIKE 4; RECQL4</td></tr></tbody></table></div></div><p><i>RECQL4</i>, pathogenic variants of which cause RTS, encodes ATP-dependent DNA helicase Q4, a member of the RecQ DNA helicase family, categorized by a 3'-5' polarity of unwinding double-stranded DNA and RNA-DNA hybrids to produce single-stranded DNA templates. At least five RecQ human paralogs with distinct but partially overlapping roles are known: <i>RECQL</i>, <i>BLM</i>, <i>WRN</i>, <i>RECQL4</i>, and <i>RECQL5</i>. Pathogenic variants in <i>BLM</i> are associated with <a href="/books/n/gene/bloom/">Bloom syndrome</a>; pathogenic variants in <i>WRN</i> are associated with <a href="/books/n/gene/werner/">Werner syndrome</a>; both are <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> instability conditions characterized by predisposition to cancer and/or premature aging. These features are shared by <i>RECQL4</i>-associated autosomal recessive RTS and by the phenotypically overlapping RAPADILINO and BGS, characterized by genetic instability, growth deficiency, and cancer predisposition. To date, no human disease has been associated with <i>RECQL</i> or <i>RECQL5</i>.</p><p>RecQ helicases are DNA helicases (enzymes that promote DNA unwinding, allowing many basic cellular processes to occur) that play a role in maintaining <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> integrity at various stages of DNA processing (replication, <a class="def" href="/books/n/gene/glossary/def-item/recombination/">recombination</a>, repair, telomere maintenance) but also in translation, RNA processing, mtDNA maintenance, and chromosome <a class="def" href="/books/n/gene/glossary/def-item/segregation/">segregation</a> [<a class="bk_pop" href="#rts.REF.croteau.2014.519">Croteau et al 2014</a>, <a class="bk_pop" href="#rts.REF.lu.2014.e1226">Lu et al 2014</a>]. Since they act in virtually all aspects of DNA metabolism, perturbation of their expression and biochemical activity leads to <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> instability, resulting in disease and cancer predisposition [<a class="bk_pop" href="#rts.REF.bochman.2014.e963429">Bochman 2014</a>].</p><p><b>Gene structure.</b>
<i>RECQL4</i> has 21 exons. The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> has a coding sequence consisting of 3,627 bases based on the <a class="def" href="/books/n/gene/glossary/def-item/open-reading-frame/">open reading frame</a> of the <a href="/nuccore/NM_004260.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_004260.3</a> <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a>. While most human genes have large introns, <i>RECQL4</i> has 13 introns that are fewer than 100 bp in length, which is near the minimum <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> length for efficient <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> estimated in model organisms [<a class="bk_pop" href="#rts.REF.wang.2002.165">Wang et al 2002</a> and references therein]. For a detailed summary of gene and protein information, see <a href="/books/NBK1237/#rts.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Approximately 50 different pathogenic variants spanning exons 5 through 21 and introns 1 through 17 have been published [<a class="bk_pop" href="#rts.REF.siitonen.2009.151">Siitonen et al 2009</a>]. Interestingly, small deletions that occur in the short introns are pathogenic because they render the <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> too short for efficient <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> [<a class="bk_pop" href="#rts.REF.wang.2002.165">Wang et al 2002</a>, <a class="bk_pop" href="#rts.REF.wang.2003.669">Wang et al 2003</a>, <a class="bk_pop" href="#rts.REF.jin.2008.643">Jin et al 2008</a>]. See <a href="/books/NBK1237/#rts.molgen.TA">Table A</a>, <b>Genes and Databases</b>.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>RECQL4</i> encodes ATP-dependent DNA helicase Q4, a protein [<a class="bk_pop" href="#rts.REF.kitao.1998.443">Kitao et al 1998</a>] of 1,208 amino acids (<a href="/protein/NP_004251.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_004251.3</a>) that belongs to the family of proteins known as RecQ helicases. RecQ helicases all share a conserved 350-amino acid helicase region consisting of seven consensus motifs, with 42%-44% identity in this region; they all have ATP- and Mg<sup>++</sup>-binding sites. RecQ helicases are found in many species including worms, bacteria, and yeast.</p><p>The exact role of ATP-dependent DNA helicase Q4 is not known; several lines of work show that it likely has diverse biologic functions [<a class="bk_pop" href="#rts.REF.larizza.2010.2">Larizza et al 2010</a>]. These include roles in DNA replication [<a class="bk_pop" href="#rts.REF.sangrithi.2005.887">Sangrithi et al 2005</a>, <a class="bk_pop" href="#rts.REF.matsuno.2006.4843">Matsuno et al 2006</a>, <a class="bk_pop" href="#rts.REF.wu.2008.130">Wu et al 2008</a>], DNA repair [<a class="bk_pop" href="#rts.REF.kumata.2007.556">Kumata et al 2007</a>, <a class="bk_pop" href="#rts.REF.schurman.2009.3470">Schurman et al 2009</a>, <a class="bk_pop" href="#rts.REF.singh.2010.358">Singh et al 2010</a>], and telomere maintenance [<a class="bk_pop" href="#rts.REF.ghosh.2012.196">Ghosh et al 2012</a>]. Recql4 has been shown in mouse models to play a role in normal skeletal development as well as in hematopoiesis [<a class="bk_pop" href="#rts.REF.smeets.2014.3551">Smeets et al 2014</a>, <a class="bk_pop" href="#rts.REF.lu.2015.1077">Lu et al 2015</a>, <a class="bk_pop" href="#rts.REF.ng.2015.e1005160">Ng et al 2015</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The majority of pathogenic variants identified thus far in individuals with <i>RECQL4</i>-related disorders are predicted to be <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants [<a class="bk_pop" href="#rts.REF.kitao.1999.82">Kitao et al 1999</a>, <a class="bk_pop" href="#rts.REF.siitonen.2009.151">Siitonen et al 2009</a>].</p></div><div id="rts.References"><h2 id="_rts_References_">References</h2><div id="rts.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="rts.REF.bochman.2014.e963429">Bochman ML. Roles of DNA helicases in the maintenance of genome integrity. <span><span class="ref-journal">Mol Cell Oncol. </span>2014;<span class="ref-vol">1</span>:e963429.</span> [<a href="/pmc/articles/PMC4905024/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4905024</span></a>] [<a href="/pubmed/27308340" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27308340</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.borg.1998.216">Borg MF, Olver IN, Hill MP. Rothmund-Thomson syndrome and tolerance of chemoradiotherapy. <span><span class="ref-journal">Australas Radiol. </span>1998;<span class="ref-vol">42</span>:216–8.</span> [<a href="/pubmed/9727245" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9727245</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.broom.2006.337">Broom MA, Wang LL, Otta SK, Knutsen AP, Siegfried E, Batanian JR, Kelly ME, Shah M. Successful umbilical cord blood stem cell transplantation in a patient with Rothmund-Thomson syndrome and combined immunodeficiency. <span><span class="ref-journal">Clin Genet. </span>2006;<span class="ref-vol">69</span>:337–43.</span> [<a href="/pubmed/16630167" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16630167</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.cao.2017.3046">Cao F, Lu L, Abrams SA, Hawthorne KM, Tam A, Jin W, Dawson B, Shypailo R, Liu H, Lee B, Nagamani SC, Wang LL. Generalized metabolic bone disease and fracture risk in Rothmund-Thomson syndrome. <span><span class="ref-journal">Hum Mol Genet. </span>2017;<span class="ref-vol">26</span>:3046–55.</span> [<a href="/pmc/articles/PMC5886079/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5886079</span></a>] [<a href="/pubmed/28486640" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28486640</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.croteau.2014.519">Croteau DL, Popuri V, Opresko PL, Bohr VA. Human RecQ helicases in DNA repair, recombination, and replication. <span><span class="ref-journal">Annu Rev Biochem. </span>2014;<span class="ref-vol">83</span>:519–52.</span> [<a href="/pmc/articles/PMC4586249/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4586249</span></a>] [<a href="/pubmed/24606147" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24606147</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.de_somer.2010.37">De Somer L, Wouters C, Morren MA, De Vos R, Van Den Oord J, Devriendt K, Meyts I. Granulomatous skin lesions complicating Varicella infection in a patient with Rothmund-Thomson syndrome and immune deficiency: case report. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2010;<span class="ref-vol">5</span>:37.</span> [<a href="/pmc/articles/PMC3009952/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3009952</span></a>] [<a href="/pubmed/21143835" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21143835</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.ghosh.2012.196">Ghosh AK, Rossi ML, Singh DK, Dunn C, Ramamoorthy M, Croteau DL, Liu Y, Bohr VA. RECQL4, the protein mutated in Rothmund-Thomson syndrome, functions in telomere maintenance. <span><span class="ref-journal">J Biol Chem. </span>2012;<span class="ref-vol">287</span>:196–209.</span> [<a href="/pmc/articles/PMC3249070/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3249070</span></a>] [<a href="/pubmed/22039056" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22039056</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.hayta_.2002.479">Hayta&#x000e7; MC, Oztun&#x000e7; H, Mete UO, Kaya M. Rothmund-Thomson syndrome: a case report. <span><span class="ref-journal">Oral Surg Oral Med Oral Pathol Oral Radiol Endod. </span>2002;<span class="ref-vol">94</span>:479–84.</span> [<a href="/pubmed/12374924" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12374924</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.hicks.2007.370">Hicks MJ, Roth JR, Kozinetz CA, Wang LL. Clinicopathologic features of osteosarcoma in patients with Rothmund-Thomson syndrome. <span><span class="ref-journal">J Clin Oncol. </span>2007;<span class="ref-vol">25</span>:370–5.</span> [<a href="/pubmed/17264332" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17264332</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.howell.2008.416">Howell SM, Bray DW. Amelanotic melanoma in a patient with Rothmund-Thomson syndrome. <span><span class="ref-journal">Arch Dermatol. </span>2008;<span class="ref-vol">144</span>:416–7.</span> [<a href="/pubmed/18347307" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18347307</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.ito.1999.354">Ito T, Tokura Y, Moriwaki S, Yasuda K, Ohnishi A, Furukawa F, Yamaizumi K, Takigawa M. Rothmund-Thomson syndrome with herpes encephalitis. <span><span class="ref-journal">Eur J Dermatol. </span>1999;<span class="ref-vol">9</span>:354–6.</span> [<a href="/pubmed/10417436" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10417436</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.jin.2008.643">Jin W, Liu H, Zhang Y, Otta SK, Plon SE, Wang LL. Sensitivity of RECQL4-deficient fibroblasts from Rothmund-Thomson syndrome patients to genotoxic agents. <span><span class="ref-journal">Hum Genet. </span>2008;<span class="ref-vol">123</span>:643–53.</span> [<a href="/pmc/articles/PMC2585174/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2585174</span></a>] [<a href="/pubmed/18504617" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18504617</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.kitao.1998.443">Kitao S, Ohsugi I, Ichikawa K, Goto M, Furuichi Y, Shimamoto A. Cloning of two new human helicase genes of the RecQ family: biological significance of multiple species in higher eukaryotes. <span><span class="ref-journal">Genomics. </span>1998;<span class="ref-vol">54</span>:443–52.</span> [<a href="/pubmed/9878247" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9878247</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.kitao.1999.82">Kitao S, Shimamoto A, Goto M, Miller RW, Smithson WA, Lindor NM, Furuichi Y. Mutations in RECQL4 cause a subset of cases of Rothmund-Thomson syndrome. <span><span class="ref-journal">Nat Genet. </span>1999;<span class="ref-vol">22</span>:82–4.</span> [<a href="/pubmed/10319867" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10319867</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.knoell.1999.444">Knoell KA, Sidhu-Malik NK, Malik RK. Aplastic anemia in a patient with Rothmund-Thomson syndrome. <span><span class="ref-journal">J Pediatr Hematol Oncol. </span>1999;<span class="ref-vol">21</span>:444–6.</span> [<a href="/pubmed/10524463" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10524463</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.kubota.1993.406">Kubota M, Yasunaga M, Hashimoto H, Kimata H, Mikawa H, Shinya A, Nishigori C. IgG4 deficiency with Rothmund-Thomson syndrome: a case report. <span><span class="ref-journal">Eur J Pediatr. </span>1993;<span class="ref-vol">152</span>:406–8.</span> [<a href="/pubmed/8319706" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8319706</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.kumata.2007.556">Kumata Y, Tada S, Yamanada Y, Tsuyama T, Kobayashi T, Dong YP, Ikegami K, Murofushi H, Seki M, Enomoto T. Possible involvement of RecQL4 in the repair of double-strand DNA breaks in Xenopus egg extracts. <span><span class="ref-journal">Biochim Biophys Acta. </span>2007;<span class="ref-vol">1773</span>:556–64.</span> [<a href="/pubmed/17320201" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17320201</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.larizza.2013.21">Larizza L, Roversi G, Verloes A. Clinical utility gene card for: Rothmund-Thomson syndrome. <span><span class="ref-journal">Eur J Hum Genet. </span>2013:21.</span> [<a href="/pmc/articles/PMC3722954/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3722954</span></a>] [<a href="/pubmed/23188052" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23188052</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.larizza.2010.2">Larizza L, Roversi G, Volpi L. Rothmund-Thomson syndrome. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2010;<span class="ref-vol">5</span>:2.</span> [<a href="/pmc/articles/PMC2826297/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2826297</span></a>] [<a href="/pubmed/20113479" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20113479</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.lindor.2000.223">Lindor NM, Furuichi Y, Kitao S, Shimamoto A, Arndt C, Jalal S. Rothmund-Thomson syndrome due to RECQ4 helicase mutations: report and clinical and molecular comparisons with Bloom syndrome and Werner syndrome. <span><span class="ref-journal">Am J Med Genet. </span>2000;<span class="ref-vol">90</span>:223–8.</span> [<a href="/pubmed/10678659" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10678659</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.lu.2014.e1226">Lu H, Fang EF, Sykora P, Kulikowicz T, Zhang Y, Becker KG, Croteau DL, Bohr VA. Senescence induced by RECQL4 dysfunction contributes to Rothmund-Thomson syndrome features in mice. <span><span class="ref-journal">Cell Death Dis. </span>2014;<span class="ref-vol">5</span>:e1226.</span> [<a href="/pmc/articles/PMC4047874/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4047874</span></a>] [<a href="/pubmed/24832598" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24832598</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.lu.2015.1077">Lu L, Harutyunyan K, Jin W, Wu J, Yang T, Chen Y, Joeng KS, Bae Y, Tao J, Dawson BC, Jiang MM, Lee B, Wang LL. RECQL4 regulates p53 function in vivo during skeletogenesis. <span><span class="ref-journal">J Bone Miner Res. </span>2015;<span class="ref-vol">30</span>:1077–89.</span> [<a href="/pubmed/25556649" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25556649</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.mak.2006.401">Mak RK, Griffiths WA, Mellerio JE. An unusual patient with Rothmund-Thomson syndrome, porokeratosis and bilateral iris dysgenesis. <span><span class="ref-journal">Clin Exp Dermatol. </span>2006;<span class="ref-vol">31</span>:401–3.</span> [<a href="/pubmed/16681588" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16681588</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.matsuno.2006.4843">Matsuno K, Kumano M, Kubota Y, Hashimoto Y, Takisawa H. The N-terminal noncatalytic region of Xenopus RecQ4 is required for chromatin binding of DNA polymerase alpha in the initiation of DNA replication. <span><span class="ref-journal">Mol Cell Biol. </span>2006;<span class="ref-vol">26</span>:4843–52.</span> [<a href="/pmc/articles/PMC1489170/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1489170</span></a>] [<a href="/pubmed/16782873" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16782873</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.mehollinray.2008.w626">Mehollin-Ray AR, Kozinetz CA, Schlesinger AE, Guillerman RP, Wang LL. Radiographic abnormalities in Rothmund-Thomson syndrome and genotype-phenotype correlation with RECQL4 mutation status. <span><span class="ref-journal">AJR Am J Roentgenol. </span>2008;<span class="ref-vol">191</span>:W62-6.</span> [<a href="/pubmed/18647888" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18647888</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.narayan.2001.210">Narayan S, Fleming C, Trainer AH, Craig JA. Rothmund-Thomson syndrome with myelodysplasia. <span><span class="ref-journal">Pediatr Dermatol. </span>2001;<span class="ref-vol">18</span>:210–2.</span> [<a href="/pubmed/11438000" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11438000</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.ng.2015.e1005160">Ng AJ, Walia MK, Smeets MF, Mutsaers AJ, Sims NA, Purton LE, Walsh NC, Martin TJ, Walkley CR. The DNA helicase recql4 is required for normal osteoblast expansion and osteosarcoma formation. <span><span class="ref-journal">PLoS Genet. </span>2015;<span class="ref-vol">11</span>:e1005160.</span> [<a href="/pmc/articles/PMC4393104/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4393104</span></a>] [<a href="/pubmed/25859855" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25859855</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.pianigiani.2001.422">Pianigiani E, De Aloe G, Andreassi A, Rubegni P, Fimiani M. Rothmund-Thomson syndrome (Thomson-type) and myelodysplasia. <span><span class="ref-journal">Pediatr Dermatol. </span>2001;<span class="ref-vol">18</span>:422–5.</span> [<a href="/pubmed/11737690" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11737690</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.piquerocasals.2002.312">Piquero-Casals J, Okubo AY, Nico MM. Rothmund-Thomson syndrome in three siblings and development of cutaneous squamous cell carcinoma. <span><span class="ref-journal">Pediatr Dermatol. </span>2002;<span class="ref-vol">19</span>:312–6.</span> [<a href="/pubmed/12220274" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12220274</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.porter.1999.452">Porter WM, Hardman CM, Abdalla SH, Powles AV. Haematological disease in siblings with Rothmund-Thomson syndrome. <span><span class="ref-journal">Clin Exp Dermatol. </span>1999;<span class="ref-vol">24</span>:452–4.</span> [<a href="/pubmed/10606946" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10606946</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.potozkin.1991.162">Potozkin JR, Geronemus RG. Treatment of the poikilodermatous component of the Rothmund-Thomson syndrome with the flashlamp-pumped pulsed dye laser: a case report. <span><span class="ref-journal">Pediatr Dermatol. </span>1991;<span class="ref-vol">8</span>:162–5.</span> [<a href="/pubmed/1923988" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1923988</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.sangrithi.2005.887">Sangrithi MN, Bernal JA, Madine M, Philpott A, Lee J, Dunphy WG, Venkitaraman AR. Initiation of DNA replication requires the RECQL4 protein mutated in Rothmund-Thomson syndrome. <span><span class="ref-journal">Cell. </span>2005;<span class="ref-vol">121</span>:887–98.</span> [<a href="/pubmed/15960976" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15960976</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.schurman.2009.3470">Schurman SH, Hedayati M, Wang Z, Singh DK, Speina E, Zhang Y, Becker K, Macris M, Sung P, Wilson DM 3rd, Croteau DL, Bohr VA. Direct and indirect roles of RECQL4 in modulating base excision repair capacity. <span><span class="ref-journal">Hum Mol Genet. </span>2009;<span class="ref-vol">18</span>:3470–83.</span> [<a href="/pmc/articles/PMC2729667/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2729667</span></a>] [<a href="/pubmed/19567405" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19567405</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.siitonen.2009.151">Siitonen HA, Sotkasiira J, Biervliet M, Benmansour A, Capri Y, Cormier-Daire V, Crandall B, Hannula-Jouppi K, Hennekam R, Herzog D, Keymolen K, Lipsanen-Nyman M, Miny P, Plon SE, Riedl S, Sarkar A, Vargas FR, Verloes A, Wang LL, K&#x000e4;&#x000e4;ri&#x000e4;inen H, Kestil&#x000e4; M. The mutation spectrum in RECQL4 diseases. <span><span class="ref-journal">Eur J Hum Genet. </span>2009;<span class="ref-vol">17</span>:151–8.</span> [<a href="/pmc/articles/PMC2986053/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2986053</span></a>] [<a href="/pubmed/18716613" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18716613</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.simon.2010.1575">Simon T, Kohlhase J, Wilhelm C, Kochanek M, De Carolis B, Berthold F. Multiple malignant diseases in a patient with Rothmund-Thomson syndrome with RECQL4 mutations: case report and literature review. <span><span class="ref-journal">Am J Med Genet A. </span>2010;<span class="ref-vol">152A</span>:1575–9.</span> [<a href="/pubmed/20503338" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20503338</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.singh.2010.358">Singh DK, Karmakar P, Aamann M, Schurman SH, May A, Croteau DL, Burks L, Plon SE, Bohr VA. The involvement of human RECQL4 in DNA double-strand break repair. <span><span class="ref-journal">Aging Cell. </span>2010;<span class="ref-vol">9</span>:358–71.</span> [<a href="/pmc/articles/PMC4624395/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4624395</span></a>] [<a href="/pubmed/20222902" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20222902</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.smeets.2014.3551">Smeets MF, DeLuca E, Wall M, Quach JM, Chalk AM, Deans AJ, Heierhorst J, Purton LE, Izon DJ, Walkley CR. The Rothmund-Thomson syndrome helicase RECQL4 is essential for hematopoiesis. <span><span class="ref-journal">J Clin Invest. </span>2014;<span class="ref-vol">124</span>:3551–65.</span> [<a href="/pmc/articles/PMC4109528/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4109528</span></a>] [<a href="/pubmed/24960165" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24960165</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.spurney.1998.494">Spurney C, Gorlick R, Meyers PA, Healey JH, Huvos AG. Multicentric osteosarcoma, Rothmund-Thomson syndrome, and secondary nasopharyngeal non-Hodgkin's lymphoma: a case report and review of the literature. <span><span class="ref-journal">J Pediatr Hematol Oncol. </span>1998;<span class="ref-vol">20</span>:494–7.</span> [<a href="/pubmed/9787328" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9787328</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.stinco.2008.154">Stinco G, Governatori G, Mattighello P, Patrone P. Multiple cutaneous neoplasms in a patient with Rothmund-Thomson syndrome: case report and published work review. <span><span class="ref-journal">J Dermatol. </span>2008;<span class="ref-vol">35</span>:154–61.</span> [<a href="/pubmed/18346259" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18346259</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.wang.2003.669">Wang LL, Gannavarapu A, Kozinetz CA, Levy ML, Lewis RA, Chintagumpala MM, Ruiz-Maldanado R, Contreras-Ruiz J, Cunniff C, Erickson RP, Lev D, Rogers M, Zackai EH, Plon SE. Association between osteosarcoma and deleterious mutations in the RECQL4 gene in Rothmund-Thomson syndrome. <span><span class="ref-journal">J Natl Cancer Inst. </span>2003;<span class="ref-vol">95</span>:669–74.</span> [<a href="/pubmed/12734318" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12734318</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.wang.2001.11">Wang LL, Levy ML, Lewis RA, Chintagumpala MM, Lev D, Rogers M, Plon SE. Clinical manifestations in a cohort of 41 Rothmund-Thomson syndrome patients. <span><span class="ref-journal">Am J Med Genet. </span>2001;<span class="ref-vol">102</span>:11–7.</span> [<a href="/pubmed/11471165" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11471165</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.wang.2002.165">Wang LL, Worley K, Gannavarapu A, Chintagumpala MM, Levy ML, Plon SE. Intron size constraint as a mutational mechanism in Rothmund-Thomson syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2002;<span class="ref-vol">71</span>:165–7.</span> [<a href="/pmc/articles/PMC384974/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC384974</span></a>] [<a href="/pubmed/12016592" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12016592</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rts.REF.wu.2008.130">Wu J, Capp C, Feng L, Hsieh TS. Drosophila homologue of the Rothmund-Thomson syndrome gene: essential function in DNA replication during development. <span><span class="ref-journal">Dev Biol. </span>2008;<span class="ref-vol">323</span>:130–42.</span> [<a href="/pmc/articles/PMC2600506/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2600506</span></a>] [<a href="/pubmed/18755177" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18755177</span></a>]</div></li></ul></div></div><div id="rts.Chapter_Notes"><h2 id="_rts_Chapter_Notes_">Chapter Notes</h2><div id="rts.Author_Notes"><h3>Author Notes</h3><p>Dr Wang is a pediatric oncologist at Texas Children's Cancer Center with particular interest in treating children with solid tumors, including osteosarcoma.</p><p>Dr Wang's <a href="https://www.texaschildrens.org/find-a-doctor/lisa-lynn-wang-md" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">web page</a></p><p>Dr Plon is a board-certified geneticist with expertise in cancer genetics and the control of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> stability. She directs the Baylor Cancer Genetics Clinic at Texas Children's Hospital/Baylor College of Medicine and is actively involved in genetic evaluation and counseling for families at increased risk for cancer.</p><p>Dr Plon's <a href="https://www.texaschildrens.org/find-a-doctor/sharon-e-plon-md-phd-facmg" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">web page</a></p></div><div id="rts.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>3 January 2019 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>11 August 2016 (bp) Revision: POIKTMP added to <a href="#rts.Differential_Diagnosis">Differential Diagnosis</a></div></li><li class="half_rhythm"><div>3 December 2015 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>6 June 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>7 April 2009 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>2 October 2006 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> clinically available</div></li><li class="half_rhythm"><div>26 September 2006 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>5 January 2005 (sp) Revision: <a href="#rts.Genetically_Related_Allelic_Disorder">Genetically Related Disorders</a></div></li><li class="half_rhythm"><div>9 June 2004 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>19 April 2004 (cd) Revision: clinical testing availability</div></li><li class="half_rhythm"><div>31 May 2002 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>6 October 1999 (me) Review posted live</div></li><li class="half_rhythm"><div>1 July 1999 (sp) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1237</span><span class="label">PMID: <a href="/pubmed/20301415" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301415</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/rbs/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/rotor/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1237&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1237/?report=reader">PubReader</a></li><li><a href="/books/NBK1237/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1237" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1237" style="display:none" title="Cite this Page"><div class="bk_tt">Wang LL, Plon SE. Rothmund-Thomson Syndrome. 1999 Oct 6 [Updated 2019 Jan 3]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1237/pdf/Bookshelf_NBK1237.pdf">PDF version of this page</a> (468K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#rts.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#rts.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#rts.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#rts.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#rts.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#rts.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#rts.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#rts.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#rts.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#rts.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#rts.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=9401[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">RECQL4</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1467490" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1467490" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1467490" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1467490" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20113479" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Rothmund-Thomson syndrome.</a><span class="source">[Orphanet J Rare Dis. 2010]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Rothmund-Thomson syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Larizza L, Roversi G, Volpi L. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Orphanet J Rare Dis. 2010 Jan 29; 5:2. Epub 2010 Jan 29.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29462647" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Novel pathogenic RECQL4 variants in Chinese patients with Rothmund-Thomson syndrome.</a><span class="source">[Gene. 2018]</span><div class="brieflinkpop offscreen_noflow">Novel pathogenic RECQL4 variants in Chinese patients with Rothmund-Thomson syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gui B, Song Y, Hu X, Li H, Qin Z, Su J, Li C, Fan X, Li M, Luo J, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Gene. 2018 May 15; 654:110-115. Epub 2018 Feb 17.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29367366" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Rothmund-Thomson syndrome (RTS) with osteosarcoma due to &lt;i&gt;RECQL4&lt;/i&gt; mutation.</a><span class="source">[BMJ Case Rep. 2018]</span><div class="brieflinkpop offscreen_noflow">Rothmund-Thomson syndrome (RTS) with osteosarcoma due to &lt;i&gt;RECQL4&lt;/i&gt; mutation.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Salih A, Inoue S, Onwuzurike N. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">BMJ Case Rep. 2018 Jan 23; 2018. Epub 2018 Jan 23.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25120469" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Rothmund-thomson syndrome: a 13-year follow-up.</a><span class="source">[Case Rep Dermatol. 2014]</span><div class="brieflinkpop offscreen_noflow">Rothmund-thomson syndrome: a 13-year follow-up.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Guerrero-González GA, Martínez-Cabriales SA, Hernández-Juárez AA, de Jesús Lugo-Trampe J, Espinoza-González NA, Gómez-Flores M, Ocampo-Candiani J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Case Rep Dermatol. 2014 May; 6(2):176-9. Epub 2014 Jul 11.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27748098" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hereditary Fibrosing Poikiloderma with Tendon Contractures, Myopathy, and Pulmonary Fibrosis</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hereditary Fibrosing Poikiloderma with Tendon Contractures, Myopathy, and Pulmonary Fibrosis<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mercier S, Küry S, Barbarot S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301415" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301415" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040da3dde0891169563c79">Rothmund-Thomson Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Rothmund-Thomson Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:32:19-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE891F00E03F49810000000009BC03E6&amp;ncbi_session=CE891F00E040DA31_2492SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1237%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1237&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1237/&amp;ncbi_pagename=Rothmund-Thomson Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE891F00E040DA31_2492SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>